14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $40.39 $44.07 Friday, 3rd May 2024 IONS stock ended at $41.97. This is 2.60% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $41.93 to a day high of $43.76.
90 days $40.39 $51.98
52 weeks $34.79 $54.44

Historical Ionis Pharmaceuticals prices

Date Open High Low Close Volume
Jan 17, 2024 $50.50 $51.31 $50.20 $51.29 1 761 495
Jan 16, 2024 $52.44 $53.17 $50.62 $51.03 1 147 689
Jan 12, 2024 $53.68 $54.44 $53.11 $53.54 826 882
Jan 11, 2024 $51.86 $53.64 $51.21 $53.55 1 128 806
Jan 10, 2024 $52.83 $53.43 $52.09 $52.21 737 841
Jan 09, 2024 $52.27 $52.95 $51.61 $52.88 978 892
Jan 08, 2024 $50.55 $52.37 $49.82 $52.32 1 018 884
Jan 05, 2024 $50.90 $50.90 $50.05 $50.70 818 857
Jan 04, 2024 $51.58 $52.25 $50.64 $51.48 1 212 524
Jan 03, 2024 $52.49 $52.78 $51.55 $51.59 1 623 226
Jan 02, 2024 $51.41 $54.18 $51.41 $52.87 2 069 687
Dec 29, 2023 $50.13 $50.63 $49.64 $50.59 1 081 893
Dec 28, 2023 $50.25 $50.51 $49.71 $50.50 1 029 972
Dec 27, 2023 $51.31 $51.32 $49.95 $50.16 943 603
Dec 26, 2023 $51.63 $52.25 $51.17 $51.30 733 661
Dec 22, 2023 $49.81 $51.74 $49.61 $51.19 1 540 097
Dec 21, 2023 $48.83 $49.88 $48.80 $49.11 812 060
Dec 20, 2023 $50.17 $50.43 $48.26 $48.33 1 294 894
Dec 19, 2023 $50.90 $51.00 $49.58 $50.31 1 286 871
Dec 18, 2023 $49.29 $50.87 $49.25 $50.71 985 449
Dec 15, 2023 $50.12 $51.13 $49.27 $49.70 1 883 924
Dec 14, 2023 $49.51 $50.93 $48.35 $49.82 1 511 423
Dec 13, 2023 $49.35 $49.95 $48.50 $49.13 1 623 391
Dec 12, 2023 $49.36 $49.48 $48.43 $49.46 970 089
Dec 11, 2023 $48.72 $49.20 $47.93 $49.18 771 582
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT